FDA regulates liquid pediatric medicines; New extended-release oral suspension antihistamine launches;

> In a guidance document, the FDA advised using flow restrictors for over-the-counter pediatric liquid drugs that contain acetaminophen. More

> FSC Pediatrics announced the launch of Karbinal ER, which it touts as the only 1st generation extended-release oral suspension antihistamine available in the U.S. More

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.